MedQuist eyes return to Nasdaq
MedQuist, a medical transcription and dictation software and services company, is hoping to return to the Nasdaq stock exchange in November.
The Laurel, N.J.-based MedQuist lost its listing on the NASDAQ National Market in June 2004 after it failed to report financial results in a timely manner. In early 2004, the company uncovered substantial irregularities in how clients were billed and has spent the past three years reforming policies and fixing its financials.
The firm said its financial reports are current and that it intends to apply for its stock to be listed on the Nasdaq Global Select Market on or around Nov. 9.
The Laurel, N.J.-based MedQuist lost its listing on the NASDAQ National Market in June 2004 after it failed to report financial results in a timely manner. In early 2004, the company uncovered substantial irregularities in how clients were billed and has spent the past three years reforming policies and fixing its financials.
The firm said its financial reports are current and that it intends to apply for its stock to be listed on the Nasdaq Global Select Market on or around Nov. 9.